Effects of stress and stress hormones on amyloid-\beta protein and plaque deposition

Journal of Alzheimer's Disease

Volumn 18, Issue 2, 2009, Pages 459-469

  Dong, Hongxin ^a   Csernansky, John G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Corticotrophin releasing factor (CRF) and receptors (CRFRs); Hypothalamic pituitary adrenal (HPA) axis; Stress; Tg2576 mice

Indexed keywords

AMYLOID BETA PROTEIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; STRESS HORMONE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHRONIC STRESS; CONTROLLED STUDY; DISEASE COURSE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL STRESS; MOUSE; NONHUMAN; PATHOGENESIS; PHYSICAL STRESS; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE;

EID: 70350492582     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1152     Document Type: Review

References (107)

1. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW(1991) The topological and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1, 103-116.
2. Katzman R (1986) Alzheimer's disease. N Engl J Med 314, 964-973. (Pubitemid 16129832)
3. Storandt M, Grant EA, Miller JP, Morris JC (2002) Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 59, 1034-1041.
4. Stozicḱa Z, Zilka N, Nov́ak M (2007) Risk and protective factors for sporadic Alzheimer's disease. Acta Virol 51, 205-222.
5. Bruandet A, Richard F, Bombois S, Maurage CA, Deramecourt V, Lebert F, Amouyel P, Pasquier F (2009) Alzheimer's disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry 80, 133-139.
6. EsiriMM,Nagy Z, Smith MZ, Barnetson L, Smith AD(1999) Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354, 919-920.
7. Sima AA, Li ZG (2006) Diabetes and Alzheimer's disease - is there a connection? Rev Diabet Stud 3, 161-168.
8. Csernansky JG, Dong H, Fagan AM, Wang L, Xiong C, Holtzman DM, Morris JC (2006) Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry 163, 2164-2169.
9. Kang JE, Cirrito JR, Dong H, Csernansky JG, Holtzman DM (2007) Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc Natl Acad Sci U S A 104, 10673-10678.
10. Fuchs E, Flugge G (1998) Stress, glucocorticoids and structural plasticity of the hippocampus. Neurosci Biobehav Rev 23, 295-300.
11. Lucassen PJ, Heine VM, Muller MB, van der Beek EM, Wiegant VM, De Kloet ER, Joels M, Fuchs E, Swaab DF, CzehB(2006) Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets 5, 531-546.
12. Miller DB, O'Callaghan JP (2003) Effects of aging and stress on hippocampal structure and function. Metabolism 52, 17-21.
13. Sapolsky RM (1003) Potential behavioral modification of glucocorticoid damage to the hippocampus. Behav Brain Res 57, 175-182.
14. Swaab DF, Bao AM, Lucassen PJ (2005) The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 4, 141-194.
15. Heim C, NemeroffCB(2001) The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 49, 1023-1039.
16. Heinrichs SC, De Souza EB (1999) Corticotropin-releasing factor antagonists, binding-protein and receptors: implications for central nervous system disorders. Baillieres Best Pract Res Clin Endocrinol Metab 13, 541-554.
17. Pariante CM (2003) Depression, stress and the adrenal axis. J Neuroendocrinol 15, 811-812.
18. Csernansky JG, Wang L, Joshi S, Miller JP, Gado M, Kido D, McKeel D, Morris JC, Miller MI (2000) Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Neurology 55, 1636-1643.
19. Jack CR, Peterson RC, O'Brien PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 42, 183-188.
20. Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M, Hanninen T, Vainio P, Soininen H (1996) Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and vascular dementia: an MRI study. Neurology 46, 678-681.
21. Murphy DG, DeCarli CD, Daly E, Gillette JA, McIntosh AR, Haxby JV, Teichberg D, Schapiro MB, Rapoport SI, Horwitz B (1993) Volumetric magnetic resonance imaging in men with dementia of the Alzheimer's type: correlations with disease severity. Biol Psych 34, 612-621.
22. McEwen BS (2000) The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886, 172-189.
23. Buchanan KL (2000) Stress and the evolution of conditiondependent signals. Trends Ecol Evol 15, 156-160.
24. Kerr DS, CampbellLW, Applegate MD,Brodish A, Landfield PW (1991) Chronic stress-induced acceleration of electrophysiologic and morphometric biomarkers of hippocampal aging. J Neurosci 11, 1316-1324.
25. McEwen BS, Magarinos AM (1997) Stress effects on morphology and function of the hippocampus. Ann N Y Acad Sci 821, 271-284
26. McEwen BS (2007) Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87, 873-904.
27. Sapolsky RM(1992), Stress, the Aging Brain, and the Mechanisms of Neuron Death. Cambridge, Massachusetts; MIT Press.
28. Magariños AM, McEwen BS (1995) Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience 69, 83-88.
29. Watanabe Y, Gould E, McEwen BS (1992) Stress induces atrophy of apical dendrites of hippocampal CA2 pyramidal neuron. Brain Res 588, 341-345.
30. Gould E, McEwen BS, Tanapat P, Galea LA, Fuchs E (1997) Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 17, 2492-2498.
31. Murakami S, Imbe H, Morikawa Y, Kubo C, Senba E (2005) Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly.Neurosci Res 53, 129-139
32. Coburn-Litvak PS, Pothakos K, Tata DA, McCloskey DP, Anderson BJ (2003) Chronic administration of corticosterone impairs spatial reference memory before spatial working memory in rats. Neurobiol Learning Mem 80, 11-23.
33. Donley MP, Schulkin J, Rosen JB (2005) Glucocorticoid receptor antagonism in the basolateral amygdala and ventral hippocampus interferes with long-term memory of contextual fear.Behav Brain Res 164, 197-205.
34. Lowy MT, Gault L, Yamamoto BK (1993) Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus. J Neurochem 61, 1957-1960.
35. Venero C, Borrell J (1999) Rapid glucocorticoid effects on excitatory amino acid levels in the hippocampus: A microdialysis study in freely moving rats. Eur J Neurosci 11, 2465-2473.
36. Baker KB, Kim JJ (2002) Effects of Stress and Hippocampal NMDA Receptor Antagonism on Recognition Memory in Rats. Learn Mem 9, 58-65.
37. Son GH,Geum D, Chung S, Kim EJ, Jo JH, Kim CM, Lee KH, Kim H, Choi S, KimHT, Lee CJ, KimK (2006) Maternal stress produces learning deficits associated with impairment of NMDA receptor-mediated synaptic plasticity. J Neurosci 26, 3309-3318.
38. Weiland NG, Orchinik M, Tanapat P (1997) Chronic corticosterone treatment induces parallel changes in N-methyl- D-aspartate receptor subunit messenger RNA levels and antagonist binding sites in the hippocampus. Neuroscience 78, 653-662.
39. Jacobson L, Sapolsky R (1991) The role of the hippocampus in feedback regulation of the hypothalamic-pituitaryadrenocortical axis. Endocrine Rev 12, 118-134.
40. De Souza-Talarico JN, Caramelli P, Nitrini R, Chaves EC (2008) Effect of cortisol levels on working memory performance in elderly subjects with Alzheimer's disease. Arq Neuropsiquiatr 66, 619-624.
41. Peskind ER, Wilkinson CW, Petrie EC, Schellenberg GD, Raskind MA (2001) Increased CSF cortisol in AD is a function of APOE genotype. Neurology 56, 1094-1098.
42. Weiner MF,Vobach S, Olsson K, Svetlik D, Risser RC (1997) Cortisol secretion and Alzheimer's disease progression. Biol Psychiatry 42, 1030-1038.
43. Davis KL, Davis BM, Greenwald BS, Mohs RC, Math́e AA, Johns CA, Horvath TB (1986) Cortisol and Alzheimer's disease, I: Basal studies. Am J Psychiatry 143, 300-305.
44. Rasmussen S, Nasman B, Carlstrom K, Olsson T (2002) Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease. Dement Geriatr Cogn Disord 13, 74-79.
45. Swanwick GRJ, Kirby M, Bruce I, Buggy F, Coen RF, Coakley D, Lawlor BA(1998) Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's Disease. Am J Psychiatry 155, 286-289.
46. Umegaki H, Ikari H, Nakahata H, Endo H, Suzuki Y, Ogawa O, Nakamura A, Yamamoto T, Iguchi A (2000) Plasma cortisol levels in elderly female subjects with Alzheimer's disease: A cross-sectional and longitudinal study. Brain Res 881, 241-243.
47. Pedersen WA, Wan R, Mattson MP (2001) Impact of aging on stress-responsive neuroendocrine systems. Mech Ageing Dev 122, 963-983.
48. Nasman B, Olsson T, Viitanen M, Carlstr̈om K (1995) A subtle disturbance in the feedback regulation of the hypothalamic-pituitary-adrenal axis in the early phase of Alzheimer's disease. Psychoneuroendocrinology 20, 211-220.
49. Hoogendijk WJ, Meynen G, Endert E, Hofman MA, Swaab DF (2006) Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression. Neurobiol Aging 27, 780.e1-780.e2.
50. Bissette G, Reynolds GP, Kilts CD, Widerlöv E, Nemeroff CB (1985) Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type: reduced cortical and striatal concentrations JAMA 254, 3067-3069.
51. De Souza EB (1988) CRH defects in Alzheimer's and other neurologic diseases. Hosp Pract (Off Ed) 23, 59-71.
52. Pomara N, Singh RR, Deptula D, LeWitt PA, Bissette G, Stanley M, Nemeroff CB (1989) CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites. Biol Psychiatry 26, 500-504.
53. Whitehouse PJ, Vale WW, Zweig RM, Singer HS, Mayeux R, Kuhar MJ, Price DL, De Souza EB (1987) Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy. Neurology 37, 905-909.
54. Behan DP, Heinrichs SC, Troncoso JC, Liu XJ, Kawas CH, Ling N, De Souza EB (1995) Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 378, 284-287.
55. De Souza EB (1995) Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20, 789-819.
56. Davis KL, Mohs RC, Marin DB, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V (1999) Neuropeptide abnormalities in patients with early Alzheimer disease. Arch Gen Psychiatry 56, 981-987. (Pubitemid 29526380)
57. Hibbard C, Yau JLW, Seckl JR (2000) Glucocorticoids and the ageing hippocampus. J Anat 197, 553-562.
58. Landfield P,Waymire J, Lynch G (1978) Hippocampal aging and adrenocorticoids: Quantitative correlations. Science 202, 1098-1102.
59. Issa A, Gauthier S, Meaney MJ (1990) Hypothalamicpituitary- adrenal activity in aged cognitively impaired and cognitively unimpaired aged rats. J Neurosci 10, 3247-3254.
60. Montaron MF, Drapeau E, Dupret D, Kitchener P, Aurousseau C, Le Moal M, Piazza PV, Abrous DN (2006) Lifelong corticosterone level determines age-related decline in neurogenesis and memory. Neurobiol Aging 27, 645-654
61. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NPV, MeaneyMJ (1994) Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14, 2893-2903.
62. Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NPV, Thakur M, McEwen BS, Hauger RL, Meaney MJ (1998) Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neurosci 1, 69-73.
63. Lupien S, Lecours AR, Schwartz G, Sharma S, Hauger RL, Meaney MJ, Nair NPV (1996) Longitudinal study of basal cortisol levels in healthy elderly subjects: Evidence for subgroups. Neurobiol Aging 17, 95-105.
64. Jellinger K (1990) Morphology of Alzheimer's disease and related disorders. In Alzheimer's disease, epidemiology, neurochemistry, and clinics (Maurer K, Riederer P, Beckman H, eds), 61-77.
65. Price D (1986) New perspectives on Alzheimer's disease. Annu Rev Neurosci 9, 489-512.
66. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81, 741-766.
67. Sisodia SS, St George-Hyslop PH (2002) Gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat Rev Neurosci 3, 281-290.
68. Yamazaki T, Koo EH, Selkoe DJ (1997) Cell surface amyloid ?-protein precursor colocalizes with b1 integrins at substrate contact sites in neural cells. J Neurosci 17, 1004-1010.
69. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomerinduced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27, 796-807.
70. Berg L, McKeel Jr DW, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM (1998) Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 55, 326-335.
71. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, Mc- Donald B, Litchfield S, Smith A, Barnetson L, Smith AD (1995) Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia 6, 21-31.
72. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, HoltzmanDM (2005) Synaptic activity regulates interstitial fluid amyloidbeta levels in vivo. Neuron 48, 913-922.
73. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) APP processing and synaptic function. Neuron 37, 925-937.
74. Wilson RS, Schneider JA, Boyle PA, Arnold SE, Tang Y, Bennett DA (2007) Chronic distress and incidence of mild cognitive impairment. Neurology 68, 2085-2092.
75. Wilson RS, Arnold SE, Schneider JA, Kelly JF, Tang Y, Bennett DA (2006) Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology 27, 143-153.
76. Wilson RS, Evans DA, Bienias JL, Mendes de Leon CF, Schneider JA, Bennett DA (2003) Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology 61, 1479-1485.
77. O'Brien JT, Ames D, Schweitzer I, Colman P, Desmond P, Tress B (1996) Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary- adrenal axis function in depression and Alzheimer's disease. Br J Psychiatry 168, 679-687.
78. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A (1987) Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 48, 9-15.
79. Belanoff JK, Jurik J, Schatzberg LD, DeBattista C, Schatzberg AF (2002) Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone. J Mol Neurosci 19, 201-206.
80. DeBattista C, Belanoff J (2005) C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease. Curr Alzheimer Res 2, 125-129.
81. Kulstad JJ, McMillan PJ, Leverenz JB, Cook DG, Green PS, Peskind ER, Wilkinson CW, Farris W, Mehta PD, Craft S (2005) Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque. J Neuropathol Exp Neuro 64, 139-146.
82. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT,Younkin SG, Hsiao KK(1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein tr- ansgenic mice. Nature Neurosci 2, 271-276.
83. Dong H, Martin MV, Chambers S, Csernansky JG (2007) Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice mice. J Comp Neurol 500, 311-321.
84. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, A? elevation and amyloid plaques in transgenic mice. Science 274, 99-102.
85. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT (1997) APPsw transgenic mice develop age-related A? deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropath Exp Neurol 56, 965-973.
86. Dong H, Goico B, Martin M, Csernansky CA, Bertchume A, Csernansky JG (2004) Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576 mice) mutant mice by isolation stress. Neuroscience 127, 601-609.
87. Dong H, Yuede CM, Yoo HS, Martin MV, Deal C, Mace AG, Csernansky JG (2008) Corticosterone and related receptor expression are associated with increased beta-amyloid plaques in isolated Tg2576 mice mice. Neuroscience 155, 154-163.
88. Jeong YH, Park CH, Yoo J, Shin KY, Ahn SM, Kim HS, SLee SH, Emson PC, Suh YH (2006) Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model. FASEB J 20, 729-731.
89. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM (2006) Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 26, 9047-9056.
90. Rissman RA, Lee KF (2007) Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation. J Neurosci 27, 6552-6562.
91. Gallagher JP, Orozco-Cabal LF, Liu J, Shinnick-Gallagher P (2008) Synaptic physiology of central CRH system. Eur J Pharmacol 583, 215-225.
92. Orozco-Cabal L, Pollandt S, Liu J, Shinnick-Gallagher P, Gallagher JP (2006) Regulation of synaptic transmission by CRF receptors. Rev Neurosci 17, 279-307.
93. Lee KW, Kim JB, Seo JS, Kim TK, Im JY, Baek IS, Kim KS, Lee JK, Han PL (2009) Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice mice via generation of metabolic oxidative stress. J Neurochem 108, 165-175
94. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 mice transgenic mouse model of Alzheimer's disease. J Neurosci 21, 372-381.
95. De Souza EB, Battaglia G (1988) Corticotropin-releasing hormone (CRH) receptors in brain. Adv Exp Med Biol 245, 123-136.
96. Martin B, Lopez de Maturana R, Brenneman R, Walent T, Mattson MP, Maudsley S (2005) Class II G protein-coupled receptors and their ligands in neuronal function and protection. Neuromolecular Med 7, 3-36.
97. Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, Bu G, Mennerick S, Holtzman DM (2008) Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58, 42-51.
98. Liu J, Yu B, Neugebauer V, Grigoriadis DE, Rivier J, Vale WW, Shinnick-Gallagher P, Gallagher JP (2004) Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission. J Neurosci 24, 4020-4029.
99. Schmolesky MT, De Ruiter MM, De Zeeuw CI, Hansel C (2007) The neuropeptide corticotropin-releasing factor regulates excitatory transmission and plasticity at the climbing fibre-Purkinje cell synapse. Eur J Neurosci 25, 1460-1466.
100. Harkany T, Abrah́am I, Timmerman W, Laskay G, T́oth B, Sasv́ari M, Ḱonya C, Sebens JB, Korf J, Nyakas C, Zaŕandi M, Sòos K, Penke B, Luiten PG (2000) Beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci 12, 2735-2745.
101. Nakagami Y, Oda T (2002) Glutamate exacerbates amyloid ?1-42-induced impairment of long-term potentiation in rat hippocampal slices. Jpn J Pharmacol 88, 223-226.
102. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, SalterMW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8, 1051-1058.
103. Tyszkiewicz JP, Yan Z (2005) Beta-Amyloid peptides impair PKC-dependent functions of metabotropic glutamate receptors in prefrontal cortical neurons. J Neurophysiol 93, 3102-3111.
104. Coussens CM,Kerr DS, AbrahamWC(1997) Glucocorticoid receptor activation lowers the threshold for NMDA-receptordependent homosynaptic long-term depression in the hippocampus through activation of voltage-dependent calcium channels. J Neurophysiol 78, 1-9.
105. Krugers HJ, Goltstein PM, Van der Linden S, Jöels M(2006) Blockade of glucocorticoid receptors rapidly restores hippocampal CA1 synaptic plasticity after exposure to chronic stress. Eur J Neurosci 23, 3051-3055.
106. Harris-White ME, Chu T, Miller SA, Simmons M, Teter B, Nash D, Cole GM, Frautschy SA (2001) Estrogen (E2) and glucocorticoid (Gc) effects on microglia and Abeta clearance in vitro and in vivo. Neurochem Int 39, 435-448.
107. Abrah́am I, Harkany T, Horvath KM, Veenema AH, Penke B, Nyakas C, Luiten PG (2000) Chronic corticosterone administration dose-dependently modulates Abeta (1-42)- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis. J Neuroendocrinol 12, 486-494.